Asset Planning Services (Pennsylvania)’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-171
Closed 287
2019
Q3
$0 Hold
171
﹤0.01% 294
2019
Q2
$0 Hold
171
﹤0.01% 282
2019
Q1
$0 Hold
171
﹤0.01% 285
2018
Q4
$0 Hold
171
﹤0.01% 289
2018
Q3
$0 Hold
171
﹤0.01% 290
2018
Q2
$0 Hold
171
﹤0.01% 291
2018
Q1
$0 Hold
171
﹤0.01% 298
2017
Q4
$0 Hold
171
﹤0.01% 322
2017
Q3
$0 Hold
171
﹤0.01% 320
2017
Q2
$0 Hold
171
﹤0.01% 325
2017
Q1
$0 Hold
171
﹤0.01% 326
2016
Q4
$0 Hold
171
﹤0.01% 295
2016
Q3
$0 Hold
171
﹤0.01% 308
2016
Q2
$0 Hold
171
﹤0.01% 302
2016
Q1
$0 Hold
171
﹤0.01% 274
2015
Q4
$0 Hold
171
﹤0.01% 253
2015
Q3
$0 Hold
171
﹤0.01% 267
2015
Q2
$0 Buy
+171
New +$118 ﹤0.01% 252

Other funds holding GCVRZ

Asset Planning Services (Pennsylvania)'s GCVRZ Position: Q4 2019 in Review

Asset Planning Services (Pennsylvania) sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2019, closing a stake of 171 shares.

Asset Planning Services (Pennsylvania) first reported a position in GCVRZ in Q2 2015 and held it in 18 quarters. The position peaked at $0 in Q3 2019. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2019.

  • Asset Planning Services (Pennsylvania) reported no remaining Sanofi Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
  • Asset Planning Services (Pennsylvania) sold 171 Sanofi Contingent Value Rights shares in Q4 2019.
  • Asset Planning Services (Pennsylvania) first reported a position in Sanofi Contingent Value Rights in Q2 2015 and held it in 18 quarters.
  • Asset Planning Services (Pennsylvania)'s Sanofi Contingent Value Rights position peaked at $0 in Q3 2019.
  • 103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2019.

Based on Asset Planning Services (Pennsylvania)'s 13F filing for Q4 2019, filed 12 Feb 2020.